Illana Gozes
Illana Gozes
Professor of Clinical Biochemistry, The Lily and Avraham Gildor Chair for the Investigation of Growth Factors, Head, the Elton Laboratory for Molecular Neuroendocrinology, Department of Human Molecular Genetics and Biochemistry, Sackler Faculty of Medicine, Adams Super Center for Brain Studies and Sagol School of Neuroscience, Tel Aviv University
Geverifieerd e-mailadres voor - Homepage
Geciteerd door
Geciteerd door
Guidelines for the use and interpretation of assays for monitoring autophagy
DJ Klionsky, K Abdelmohsen, A Abe, MJ Abedin, H Abeliovich, ...
Autophagy 12 (1), 1-222, 2016
International Union of Pharmacology. XVIII. Nomenclature of receptors for vasoactive intestinal peptide and pituitary adenylate cyclase-activating polypeptide
AJ Harmar, A Arimura, I Gozes, L Journot, M Laburthe, JR Pisegna, ...
Pharmacological reviews 50 (2), 265-270, 1998
Complete sequence of a novel protein containing a femtomolar‐activity‐dependent neuroprotective peptide
M Bassan, R Zamostiano, A Davidson, A Pinhasov, E Giladi, O Perl, ...
Journal of neurochemistry 72 (3), 1283-1293, 1999
Growth factor function of vasoactive intestinal peptide in whole cultured mouse embryos
P Gressens, JM Hill, I Gozes, M Fridkin, DE Brenneman
Nature 362 (6416), 155-158, 1993
Pharmacology and functions of receptors for vasoactive intestinal peptide and pituitary adenylate cyclase‐activating polypeptide: IUPHAR review 1
AJ Harmar, J Fahrenkrug, I Gozes, M Laburthe, V May, JR Pisegna, ...
British journal of pharmacology 166 (1), 4-17, 2012
A femtomolar-acting neuroprotective peptide.
DE Brenneman, I Gozes
The Journal of clinical investigation 97 (10), 2299-2307, 1996
DJ Klionsky
Current Biology 15 (8), R282-R283, 2005
VIP: molecular biology and neurobiological function
I Gozes, DE Brenneman
Molecular neurobiology 3 (4), 201-236, 1989
Cytokine regulation of neuronal survival
DE Brenneman, M Schultzberg, T Bartfai, I Gozes
Journal of neurochemistry 58 (2), 454-460, 1992
Tubulin microheterogeneity increases with rat brain maturation
I Gozes, UZ Littauer
Nature 276 (5686), 411-413, 1978
A peptide derived from activity-dependent neuroprotective protein (ADNP) ameliorates injury response in closed head injury in mice
L Beni-Adani, I Gozes, Y Cohen, Y Assaf, RA Steingart, DE Brenneman, ...
Journal of Pharmacology and Experimental Therapeutics 296 (1), 57-63, 2001
A glia-derived signal regulating neuronal differentiation
O Blondel, C Collin, WJ McCarran, S Zhu, R Zamostiano, I Gozes, ...
Journal of Neuroscience 20 (21), 8012-8020, 2000
A neuronal microtubule-interacting agent, NAPVSIPQ, reduces tau pathology and enhances cognitive function in a mouse model of Alzheimer's disease
Y Matsuoka, Y Jouroukhin, AJ Gray, L Ma, C Hirata-Fukae, HF Li, L Feng, ...
Journal of Pharmacology and Experimental Therapeutics 325 (1), 146-153, 2008
Neuroprotective strategy for Alzheimer disease: intranasal administration of a fatty neuropeptide
I Gozes, A Bardea, A Reshef, R Zamostiano, S Zhukovsky, S Rubinraut, ...
Proceedings of the National Academy of Sciences 93 (1), 427-432, 1996
Vasoactive intestinal peptide prevents excitotoxic cell death in the murine developing brain.
P Gressens, S Marret, JM Hill, DE Brenneman, I Gozes, M Fridkin, ...
The Journal of clinical investigation 100 (2), 390-397, 1997
Cloning and characterization of the human activity-dependent neuroprotective protein
R Zamostiano, A Pinhasov, E Gelber, RA Steingart, E Seroussi, E Giladi, ...
Journal of Biological Chemistry 276 (1), 708-714, 2001
Activity-dependent neuroprotective protein: a novel gene essential for brain formation
A Pinhasov, S Mandel, A Torchinsky, E Giladi, Z Pittel, AM Goldsweig, ...
Developmental brain research 144 (1), 83-90, 2003
Activity-dependent neurotrophic factor: intranasal administration of femtomolar-acting peptides improve performance in a water maze
I Gozes, E Giladi, A Pinhasov, A Bardea, DE Brenneman
Journal of Pharmacology and Experimental Therapeutics 293 (3), 1091-1098, 2000
Davunetide in patients with progressive supranuclear palsy: a randomised, double-blind, placebo-controlled phase 2/3 trial
AL Boxer, AE Lang, M Grossman, DS Knopman, BL Miller, LS Schneider, ...
The Lancet Neurology 13 (7), 676-685, 2014
Prevention of fetal demise and growth restriction in a mouse model of fetal alcohol syndrome
CY Spong, DT Abebe, I Gozes, DE Brenneman, JM Hill
Journal of Pharmacology and Experimental Therapeutics 297 (2), 774-779, 2001
Het systeem kan de bewerking nu niet uitvoeren. Probeer het later opnieuw.
Artikelen 1–20